Pharmacogenomics,
Journal Year:
2022,
Volume and Issue:
23(6), P. 371 - 392
Published: March 21, 2022
Clozapine
(CLZ)
is
an
atypical
antipsychotic
reserved
for
patients
with
refractory
psychosis,
but
it
associated
a
significant
risk
of
severe
adverse
reactions
(ADRs)
that
are
potentiated
the
concomitant
use
alcohol.
Additionally,
pharmacogenetic
studies
have
explored
influence
several
genetic
variants
in
CYP450,
receptors
and
transporters
involved
interindividual
response
to
CLZ.
Herein,
we
systematically
review
current
multiomics
knowledge
behind
interaction
between
CLZ
alcohol
intake,
how
its
might
modulate
pharmacogenetics.
CYP1A2*1F,
*1C
other
alleles
not
yet
discovered
could
support
precision
medicine
approach
better
therapeutic
effects
fewer
ADRs.
monitoring
systems
should
be
amended
include
intake
protect
from
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(4), P. 1623 - 1623
Published: Feb. 14, 2025
Alcohol
use
disorder
(AUD)
contributes
significantly
to
the
global
burden
of
disease.
The
susceptibility
for
AUD
is
mediated
through
an
interaction
genetic
risk
factors
and
environmental
influences.
These
gene
×
environment
(G
E)
interactions
manifest
as
epigenetic
regulations
expression,
among
other
things.
Previous
research
suggests
association
between
Ganglioside
Induced
Differentiation
Associated
Protein
1
(GDAP1)
DNA
methylation
AUD.
Here,
we
investigate
dysregulation
GDAP1
in
comparing
whole
blood
saliva,
well
H3K4-trimethylation
(H3K4me3)
PBMC
(Peripheral
Blood
Mononuclear
Cell)
samples
patients
healthy
control
individuals.
Additionally,
effect
abstinence-based
therapy
was
investigated.
before
treatment
exhibit
lower
promoter
levels
H3K4me3
near
transcription
start
site.
expression
not
altered.
Following
treatment,
increased
no
longer
differed
from
There
significant
on
methylation.
We
conclude
that
epigenetically
dysregulated
patients,
responsive
at
level
H3K4me3.
It
should
be
investigated
further
establish
its
potential
a
diagnostic
biomarker.
American Journal of Psychiatry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
The
authors
provide
recommendations
on
incorporating
recent
advances
in
psychiatric
genetics
into
clinical
practice
for
mental
health
clinicians.
International
Society
Psychiatric
Genetics
Education
Committee
met
monthly
to
come
a
consensus
priority
topics
genetics.
Topics
were
then
assigned
small
teams
of
subspecialty
experts
summarize
the
current
knowledge
base
and
create
an
illustrative
case.
included,
familial
aggregation,
common
rare
genetic
variants,
epigenetics,
gene-environment
interactions,
pharmacogenomics,
counseling,
ethical
social
implications.
Each
section
was
reviewed
revised
by
all
committee
members
finalized
Chair.
Key
findings
highlight
importance
understanding
architecture
disorders,
potential
applications
information
risk
assessment,
diagnosis,
treatment
selection,
patient
education,
as
well
considerations
surrounding
use
data.
emphasizes
need
nuanced
approach
that
integrates
factors
with
environmental
experiential
holistic
model
care.
As
continues
evolve
rapidly,
clinicians
must
stay
informed
about
latest
their
Ongoing
collaboration
professionals,
effective
communication
strategies
are
crucial
harness
power
while
avoiding
pitfalls
such
determinism
stigma.
recommends
balanced
perspective
recognizes
complex
interplay
non-genetic
shaping
outcomes.
Alcohol Clinical and Experimental Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 28, 2025
Abstract
Background
Chronic
heavy
alcohol
use
is
a
major
risk
factor
for
premature
aging
and
age‐related
diseases.
DNA
methylation
(DNAm)‐based
epigenetic
clocks
are
novel
tools
predicting
biological
age.
However,
the
newest
configurations,
causality‐enriched
clocks,
have
not
been
assessed
in
context
of
consumption
disorder
(AUD).
Methods
Epigenetic
was
evaluated
sample
615
individuals
(372
AUD
patients
243
healthy
controls)
by
applying
GrimAge
Version
1
(V1)
2
(V2)
alongside
three
(CausAge,
DamAge,
AdaptAge).
A
linear
model
controlling
diagnosis,
sex,
race,
BMI,
smoking
status,
five
blood
cell
types
leveraged
to
test
associations
between
alcohol‐related
metrics
age‐adjusted
clocks.
Results
V1
V2
maintained
significant
with
drinking
behavior
measures
within
total
both
young
(<40
years
old)
old
(≥40
subgroups.
Generally,
slightly
outperformed
V1,
while
none
demonstrated
AUD.
subgroup,
DamAge
had
association
number
drinks.
Across
age
subgroups,
liver
function
enzymes,
consistently
sustained
stronger
compared
V1.
Among
fourth‐generation
exhibited
gamma‐glutamyl
transferase
(GGT)
aspartate
aminotransferase
subgroup;
CausAge
displayed
GGT
sample.
Examining
clinical
biomarkers,
showed
improved
C‐reactive
protein
Conclusions
Overall,
we
observed
moderately
performance
majority
parameters
tested.
The
lacked
but
demonstrate
complexities
inspire
further
research
dynamics.
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(16)
Published: Aug. 14, 2024
Alcohol
use
disorder
(AUD)
is
a
prominent
contributor
to
global
morbidity
and
mortality.
Its
complex
etiology
involves
genetics,
epigenetics,
environmental
factors.
We
review
progress
in
understanding
the
genetics
epigenetics
of
AUD,
summarizing
key
findings.
Advancements
technology
over
decades
have
elevated
research
from
early
candidate
gene
studies
present-day
genome-wide
scans,
unveiling
numerous
genetic
epigenetic
risk
factors
for
AUD.
The
latest
GWAS
on
more
than
one
million
participants
identified
100
variants,
largest
epigenome-wide
association
(EWAS)
blood
brain
samples
revealed
tissue-specific
changes.
Downstream
analyses
enriched
pathways,
correlations
with
other
traits,
transcriptome-wide
tissues,
drug-gene
interactions
also
discuss
limitations
future
directions,
including
increasing
power
EWAS
as
well
expanding
diversity
populations
included
these
analyses.
Larger
samples,
novel
technologies,
analytic
approaches
are
essential;
include
whole-genome
sequencing,
multiomics,
single-cell
spatial
transcriptomics,
deep-learning
prediction
variant
function,
integrated
methods
disease
prediction.
Frontiers in Behavioral Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: Jan. 26, 2023
Alcohol
use
disorder
(AUD)
is
a
worldwide
problem.
Unfortunately,
the
molecular
mechanisms
of
alcohol
misuse
are
still
poorly
understood,
therefore
successful
therapeutic
approaches
limited.
Accumulating
data
indicate
that
tendency
for
compulsive
inherited,
suggesting
genetic
background
as
an
important
factor.
However,
probability
to
develop
AUD
also
affected
by
life
experience
and
environmental
factors.
Therefore,
epigenetic
modifications
altered
over
lifetime
likely
contribute
increased
risk
misuse.
Here,
we
review
literature
looking
link
between
DNA
methylation
in
brain,
common
modification,
AUD-related
behaviors
humans,
mice
rats.
We
sum
up
main
findings,
identify
existing
gaps
our
knowledge
future
directions
research.
Expert Opinion on Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
23(10), P. 1181 - 1193
Published: May 31, 2022
Comorbidity
of
bipolar
disorder
(BD)
and
alcohol
use
(AUD)
is
very
frequent
resulting
in
detrimental
outcomes,
including
increased
mortality.
Diagnosis
AUD
BD
vice
versa
often
delayed
as
symptoms
one
mimic
obscure
the
other
one.
Evidence
for
pharmacotherapies
people
with
comorbid
remains
limited,
further
proof-of-concept
studies
are
urgently
needed.This
paper
explores
currently
available
AUD,
their
usefulness
AUD.
It
also
covers
to
some
degree
epidemiology,
diagnosis,
potential
common
neurobiological
traits
AUD.The
authors
conclude
that
more
controlled
needed
before
evidence-based
guidance
can
be
drawn
up
clinician's
use.
Since
there
no
relevant
pharmacological
interactions,
approved
medications
used
safely
BD.
For
mood
stabilization,
lithium
should
considered
first
adherent
persons
Alternatives
include
valproate,
lamotrigine,
atypical
antipsychotics,
partial
D2/D3
receptor
agonism
possibly
being
beneficial
too.
Epigenomics,
Journal Year:
2022,
Volume and Issue:
14(12), P. 793 - 810
Published: June 1, 2022
Aim:
We
systematically
reviewed
and
evaluated
current
literature
on
alcohol
consumption
DNA
methylation
(DNAm)
at
the
genome-wide
probe-wise
level
in
blood
of
adults.
Materials
&
methods:
Five
databases
(PubMed,
Embase,
Web
Science,
CINAHL
PsycInfo)
were
searched
until
20
December
2020.
Studies
assessing
effect
dependence
DNAm
not
eligible.
Results:
11
cross-sectional
studies
included
with
88
to
9643
participants.
Overall,
all
had
a
risk
bias
criteria
unclear
or
unmet.
Epigenome-wide
association
identified
between
0
5458
differentially
methylated
positions,
15
observed
least
four
studies.
Conclusion:
Potential
markers
for
have
been
identified,
but
further
validation
large
cohorts
is
needed.
Current Pharmaceutical Design,
Journal Year:
2023,
Volume and Issue:
29(27), P. 2124 - 2139
Published: July 7, 2023
Abstract:
Currently,
and
globally,
we
are
facing
the
worst
epidemic
of
psychoactive
drug
abuse
resulting
in
loss
hundreds
thousands
lives
annually.
Besides
alcohol
opioid
use
misuse,
there
has
been
an
increase
illicit
psychostimulants.
Epigenetics
is
a
relatively
novel
area
research
that
studies
heritable
alterations
gene
expression.
Long-term
administration
drugs
may
lead
to
transcriptional
changes
brain
regions
related
drug-seeking
behaviors
rewards
can
be
passed
down
transgenerationally.
Epigenetic
biomarkers
such
as
DNA
methylation
histone
modifications
contribute
disease
diagnoses.
This
review
aims
look
at
epigenetic
brought
forth
by
abuse.
Frontiers in Genetics,
Journal Year:
2024,
Volume and Issue:
15
Published: April 3, 2024
Background:
Alcohol
use
disorder
(AUD)
is
a
complex
condition
associated
with
adverse
health
consequences
that
affect
millions
of
individuals
worldwide.
Epigenetic
modifications,
including
DNA
methylation
(5
mC),
have
been
AUD
and
other
alcohol-related
traits.
Epigenome-wide
association
studies
(EWAS)
identified
differentially
methylated
genes
in
human
peripheral
brain
tissue.
More
recently,
epigenetic
also
evaluated
hydroxymethylation
hmC)
the
brain.
However,
most
work
postmortem
tissue
has
examined
bulk
In
this
study,
we
investigated
neuronal-specific
5
mC
hmC
alterations
at
CpG
sites
orbitofrontal
cortex
(OFC).
Methods:
Neuronal
nuclei
from
OFC
were
34
samples
(10
AUD,
24
non-AUD).
Reduced
representation
oxidative
bisulfite
sequencing
was
used
to
assess
genome-wide
level.
Differential
using
methylKit
R
package
significance
set
false
discovery
rate
<
0.05
differential
>
2.
Functional
enrichment
analyses
performed,
gene-level
convergence
an
independent
dataset
assessed
cortical
Results:
We
417
363
5hmC
significant
59%
gene
promoters.
Some
previously
implicated
alcohol
consumption,
SYK,
DNMT3A
for
mC,
GAD1,
DLX1,
DLX2,
GATA4
both.
Convergence
previous
study
observed
28
genes.
35
regions
hmC,
respectively.
Lastly,
GWAS
analysis
showed
Discussion:
This
reveals
methylome
hydroxymethylome
dysregulation
identifying
both
reported
potentially
novel
associations
AUD.
Our
findings
provide
new
insights
into
epigenomic
Science Technology & Human Values,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 2, 2024
New
and
emerging
forensic
genetics
technologies
offer
significant
insight
into
personal
information,
changing
the
way
that
policing
criminal
justice
uses
of
such
are
being
considered
legitimized.
In
this
article,
based
on
data
from
Central
Western
European
countries
United
States
America,
we
analyze
how
compounding,
interdependent
effects
four
technologies—massive
parallel
sequencing,
epigenetics,
DNA
phenotyping,
genetic
genealogy—facilitate
dissolving
boundaries
between
medical,
as
well
commercial
non-commercial
domains.
Mobilizing
social
epistemology
epistemic
culture
dual
analytical
lens,
argue
can
witness
emergence
an
increasingly
complex
assemblage,
fostering
dependencies
agencies,
research
scientists,
companies.
At
heart
assemblage
lies
transformation
central
knowledge
claims
distinct
roles
responsibilities
defining
legitimate
application
information
in
contexts.
The
deepening
co-dependencies
within
encourage
increased
self-governance
key
stakeholders,
to
detriment
field's
societal
accountability
legitimacy.
discussion
article
provides
a
necessary
starting
point
for
reframing
genetics’
governance.